KingAP Posted - 4 hours ago

$ELV oversold but still a lot of downside risk

LongOrShort01 Posted - 4 hours ago

$ELV $HUM $CNC $UNH https://www.wsj.com/livecoverage/nvidia-earnings-stock-market-today-dow-sp500-nasdaq-live-11-20-2024/card/dr-oz-s-cms-nomination-sparks-mixed-reaction-from-healthcare-investors-DVTEUxOdV8xJWmYgjSKv?siteid=yhoof2

RobotMumba100 Posted - 12 hours ago

$ELV soon...we will be over 400$ soon....

Stocks_Sportsbikes Posted - 13 hours ago

$ELV Anyone familiar with this from ELVs SEC page? Looks like T Rowe Price increased it's stake on Nov14th. Looking at Prices breakdown from last quarter they increased their position? Can anyone confirm?

Roquetrader007 Posted - 17 hours ago

$ELV I must be missing something here lol smh Can’t understand why we are not up like the others today lol

Roquetrader007 Posted - 18 hours ago

$ELV Any thoughts on why we are barely up today and all the other insurers minus CI are up like crazy after Dr. OZ news ?

Dyl_Dalton Posted - 18 hours ago

$ELV $WFC LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

AlenaMartin Posted - 19 hours ago

$NXPI $ELV LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

DonCorleone77 Posted - 21 hours ago

$HUM $UNH $CVS $ELV Dr. Oz spoke of expanding Medicare Advantage plans, says JPMorgan JPMorgan views President-elect Trump's nomination of Dr. Mehmet Oz to be Centers for Medicare and Medicaid Services Administrator as a surprise pick to oversee Medicare, Medicaid and the Affordable Care Act Exchanges. While there is limited information to gauge the nomination from a policy perspective, the pieces of information indicate Oz would will follow conventional Republican approach to running CMS, the analyst tells investors in a research note. The firm points out that in an interview with AARP in 2022 during his unsuccessful Senate campaign, Oz said: "We can expand Medicare Advantage plans. These plans are popular among seniors, consistently provide quality care and have a needed incentive to keep costs low." JPMorgan sees this as consistent with its expectations that CMS under Republican control would support Medicare Advantage. This is favorable for companies like Humana (HUM), UnitedHealth (UNH), CVS Health (CVS) and Elevance Health (ELV), the firm contends.

Stocks_Sportsbikes Posted - 1 day ago

$ELV HHS/CMS lawsuit Filed Nov 1st 2024 - $375 million, upgrade 2 plans to 4.0 stars, upgrade 1 plan to 3.5 stars. Review of all data for all plans year 2024-2025 possible other plans to be challenged as well. Read the lawsuit here:👇 https://www.documentcloud.org/documents/25267851-elevance_health_star_ratings June 2024 judgment Elevance awarded 1/9 contracts upgraded BCBS Georgia 👇 https://caselaw.findlaw.com/court/us-dis-crt-dis-col/116253537.html#:~:text=ELEVANCE%20HEALTH%20INC%20v.,BECERRA%20(2024)%20%7C%20FindLaw Other insurers filing suits currently against CMS/HHS - Humana, United Health, KFF, Centene Screen shots provided of current lawsuit. Still in litigation.

RobotMumba100 Posted - 1 day ago

$ELV I read again the last results...why this drop? Adjusted Diluted Earnings Per Share (EPS): $8.37 for Q3 2024, below expectations. GAAP Diluted EPS: $4.36 for Q3 2024. Total Operating Revenue: $44.7 billion, up over 5% year-over-year. Benefit Expense Ratio: 89.5% for Q3 2024, an increase of 270 basis points year-over-year. Adjusted Operating Expense Ratio: 9.6%, an improvement of 150 basis points. Adjusted Operating Gain: $2.4 billion for Q3 2024 and $8.3 billion year-to-date. Membership: 45.8 million members, flat sequentially; commercial membership grew by nearly 600,000 year-over-year. Days in Claims Payable: 42.8 days, slightly above the targeted range. Full Year Outlook for Adjusted Diluted EPS: Reduced to approximately $33. Full Year Operating Cash Flow: Expected to be approximately $4.5 billion.

jp476 Posted - 1 day ago

$ELV This goes below 350 before it gets better.

kagrawala Posted - 1 day ago

$ELV cfo and ceo jobs should be on the line imo. Be patient no need to add yet, let it bottom

LongOrShort01 Posted - 1 day ago

$ELV we need news and buybacks information!!!!

stockfrank1 Posted - 1 day ago

$ELV didn't think it would break $400. Geez

LongOrShort01 Posted - 1 day ago

$ELV dead monkey

penny_option Posted - 2 days ago

$ELV finally a Green Day in xlv. It bounced off the support. Let’s see if it lasts

iNvest4Win Posted - 2 days ago

$ELV Maybe go time.

iNvest4Win Posted - 2 days ago

$ELV Go or no go………

Simon77 Posted - 2 days ago

$ELV for swing traders, oversold divergence on all time frame. $SPY $QQQ $IWM PT $480s (the gap)

Roquetrader007 Posted - 2 days ago

$ELV Funny how the market was saying if Kamala won that these health insurance stocks would tank and if trump won we would skyrocket …hoping we just need a little more time before liftoff but this is ridiculous at this point smh lol

Jgarcapital Posted - 2 days ago

$ELV buying at these levels similar like $CI last year bounce back $100 in less than 2 months .. easy money here $500 calls cheap. Mark this and check back in February 2025

Simon77 Posted - 2 days ago

$ELV Bloomberg just gave a go to load health care. Load the cheapest valuation in the sector. $HUM $CI $HUM

nio11 Posted - 2 days ago

$ELV Anyone looking at this to rebound. UNH has rocketed higher after the expense ratio issue, but not this. Still near the year lows.

nio11 Posted - 2 days ago

$ELV Wells Fargo puts a $483 PT and buy rating.

Joaquin_Rasmussen Posted - 2 days ago

😏🚀 MYNZ We know the date of the reverse split (RS) if there will be one, but possibly a Nasdaq extension will be granted. Last time it traded, 50 million and 19 million heavy shorts attacked. Now, it has huge credibility after the TMO partnership and the meeting. The company will decide by November 25th whether or not to do an RS based on Nasdaq's response. Anyway, after the RS, I'm not worried about what happens next. A $210 billion partner TMO signing a deal with a penny stock has never happened before. I will be loading heavy on Monday. This will go to the moon like the DRUG stock recently did. The price target (PT) is $50. The squeeze will be parabolic. $ABT $ELV

KingAP Posted - 3 days ago

$ELV won’t go down forever

Shlobby Posted - 4 days ago

$Elv ator down

KingAP Posted - 5 days ago

$ELV gonna buy one more time then wait til 387

chux Posted - 5 days ago

@lextrading $ELV